A.E. VERAKSA

I.I. Skvortsov ― Stepanov City Psychiatric Hospital №3, 36, AE Fermskoe shosse, Saint-Petersburg, Russian Federation, 197341

Veraksa A.E. ― psychiatrist, psychotherapist, tel. (812) 301-79-33, e-mail: [email protected]

The article presents the analysis of therapy of patients suffering from acute endogenous psychoses (AEP) with or without catatonic symptoms during attacks. As a result of the conducted research it is established that among the patients with AEP there is a large share of those having some catatonic symptoms in the clinical picture. The analysis of therapeutic tactics showed the lack of differentiated approach to the drug treatment of patients with different clinical forms of AEP. Monotherapy with benzodiazepines should be considered as the most optimal variant for stopping AEP regardless of the existence or lack of a catatonic symptomatology.

Key words: acute endogenous psychoses, catatonic symptomatology, pharmacotherapy, benzodiazepines, antipsychotics.

REFERENCES

1. Mezhdunarodnaya klassifikatsiya bolezney (10-y peresmotr). Psikhicheskie rasstroystva i rasstroystva povedeniya (F00-F99) [International Classification of Diseases (10th revision). Mental and behavioral disorders (F00-F99)]. Rostov on Don: Feniks, 1999. 420 p.
2. Papadopulos T.F. Ostrye endogennye psikhozy [Acute endogenous psychosis]. Moscow: Meditsina, 1972. 192 p.
3. Marneros A., Pillman F. Acute and transient psychotic disorders. Psychiatriki, 2002, vol. 13, p. 276-286.
4. Wilcox J.A., Duffy P.R. The Syndrome of Catatonia. Behavioral Sciences (Basel), 2015, vol. 5, no. 4, rr. 576-588.
5. Fink M. Catatonia: A syndrome appears, disappears and is rediscovered. The Canadian Journal of Psychiatry, 2009, vol. 54, rr. 437-445.
6. Northoff G. What catatonia can tell us about ‘top-down modulation’: a neuropsychiatric hypothesis. Behavioral and Brain Sciences, 2002, vol. 25, pp. 555-577.
7. Carroll B.T. Kahlbaum’s catatonia revisited. Psychiatry and Clinical Neurosciences, 2001, vol. 55, rr. 431-436.
8. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. Am. J. Psychiatry, 2003, vol. 160, pp. 1233-1241.
9. Egorov A.Yu. Elektrosudorozhnaya terapiya pri psikhicheskikh zabolevaniyakh i ratsional’naya psikhofarmakoterapiya [Electroconvulsive therapy for mental illnesses and rational psychopharmacotherapy]. Ratsional’naya psikhofarmakoterapiya v psikhiatricheskoy praktike: rukovodstvo dlya praktikuyushchikh vrachey. Moscow: Litterra, 2014. Pp. 331-351.
10. Hashim H., Zeb-un-Nisa, Alrukn S.A., Al Madani A.A. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. Journal of Pakistan Medical Association, 2014, vol. 64, pp. 471-473.
11. Sundararajan Rajagopal. Catatonia. Advances in Psychiatric Treatment, 2007, vol. 13, pp. 51-59.
12. Bush G., Fink M., Petrides G. et al. Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 1996, vol. 93, rr. 129-136.
13. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports, 1962, vol. 10, rr. 799-812.
14. Guy W. ECDEU Assessment Manual for Psychopharmacology — Revised (DHEW Publ No ADM 76–338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976. Rr. 218-222.
15. Spravochnoe rukovodstvo po psikhofarmakologicheskim i protivoepilepticheskim preparatam, razreshennym k primeneniyu v Rossii, pod red. S.N. Mosolova [Reference guide for psychopharmacological and antiepileptic drugs, approved for use in Russia. Ed. by S.N. Mosolov]. Moscow: BINOM, 2004. 304 p.